Verallia SA
OTC:VRLAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Verallia SA
OTC:VRLAF
|
FR |
|
R
|
Ramsay Health Care Ltd
SWB:RMY
|
AU |
|
B
|
Bigcommerce Holdings Inc
F:BI1
|
US |
|
S
|
Sirona Biochem Corp
OTC:SRBCF
|
CA |
|
T
|
Ted Baker PLC
F:TEB
|
UK |
|
R
|
Rakuten Group Inc
XBER:RAK
|
JP |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
XMUN:SLL
|
AT |
Wall St Price Targets
VRLAF Price Targets Summary
Verallia SA
According to Wall Street analysts, the average 1-year price target for VRLAF is 34.254 USD with a low forecast of 30.26 USD and a high forecast of 39.323 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRLAF's stock price target?
Price Target
34.254
USD
According to Wall Street analysts, the average 1-year price target for VRLAF is 34.254 USD with a low forecast of 30.26 USD and a high forecast of 39.323 USD.
What is the Revenue forecast for Verallia SA?
Projected CAGR
2%
Over the last 6 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Verallia SA?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Verallia SA?
Projected CAGR
30%
Over the last 6 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 3 years is 30%.
